Johnson & Johnson
Baby necessities and medical needs are often associated with New Jersey-based Johnson & Johnson, making it a very profitable brand. Many investors know this, including hedge fund Levin Capital Strategies, which has been buying shares since 2006. The medical company accounts for five percent of the New York firm’s portfolio despite only raising its shares by one percent in the third quarter of 2020.
Meanwhile, Johnson & Johnson’s vaccine will be up for discussion before February 2021 ends, as vaccine experts weigh in if the single-dose vaccine can be administered for emergency use. The company has yet to receive authorization from the government.
